We provide you with 20 years of free, institutional-grade data for VRPX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VRPX. Explore the full financial landscape of VRPX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Virpax Pharmaceuticals, Inc(NASDAQ:VRPX) 
Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spr...
Website: http://www.virpaxpharma.com
Founded: 2016
CEO: Anthony P. Mack
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about VRPX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.